Short-term Mg deficiency upregulates protein kinase C isoforms in cardiovascular tissues and cells; relation to NF-kB, cytokines, ceramide salvage sphingolipid pathway and PKC-zeta: Hypothesis and review

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 1, 2014, Pages 1-21

  Altura, Burton M ^a,b,c   Shah, Nilank C ^a   Shah, Gatha J ^a   Zhang, Aimin ^a   Li, Wenyan ^a   Zheng, Tao ^a   Perez Albela, Jose Luis ^d   Altura, Bella T ^a,b,c  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b Downstate Health Sciences University   (United States)

^c Bio Defense Systems Inc   (United States)

^d Instituto Bien de Salud   (Peru)

Author keywords

Cardiac muscle; Ceramide synthase; p65; Sphingosine; Vascular muscle; Water borne magnesium

Indexed keywords

EID: 84892582774     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (95)

1. Altura BM, Altura BT. Magnesium: forgotten mineral and cardiovascular biology and atherogenesis. In: Nishizawa N, Morii H, Durlach J. New Perspectives in Magnesium Research. New York: Springer; 2007. pp: 239-260.
2. Durlach J, Bara M, Guilet-Bara A. Magnesium level in drinking water and cardiovascular risk factor: a hypothesis. Magnesium 1985; 4: 5-15.
3. Eisenberg MJ. Magnesium deficiency and sudden death. Am Heart J 1992; 124: 544-549.
4. Ford ES, Mokdad AH. Dietary magnesium intake in a national sample of US adults. J Nutr 2003; 121: 2879-2882.
5. Marier JR, Neri LC. Quantifying the role of magnesium in the interrelationship between human mortality/morbidity and water hardness. Magnesium 1985; 4: 53-59.
6. Marx A, Neutra RR. Magnesium in drinking water and deaths from ischemic heart disease. Epidemiol Rev 1997; 19: 258-272.
7. Rubenowitz E, Molin L, Axellson G, Rylander R. Magnesium in drinking water in relation to morbidity and mortality from acute myocardial infarction. Epidemiology 2000; 11: 416-421.
8. Altura BM, Altura BT. Magnesium and contraction of arterial muscle. Microvasc Res 1974; 7: 145-155.
9. Altura BM, Altura BT, Gebrewold A, Ising H, Gunther T. Magnesium deficiency and hypertension: correlation between magnesium deficient diets and microcirculatory changes in situ. Science 1984; 223: 1315-1317.
10. Altura BM, Barbour RL, Dowd TL, Wu F, Altura BT, Gupta RK. Low extracellular magnesium induces intracellular free Mg deficits, depletion of high-energy phosphates and cardiac failure in intact working hearts; A 31P-NMR study. Biochim Biophys Acta 1993; 1182: 329-332.
11. Altura BT, Memon ZI, Zhang A, Cracco RQ, Altura BM. Low levels of ionized magnesium are found in patients early after stoke which result in rapid elevation in cytosolic free calcium and spasm in cerebral vascular smooth muscle cells. Neurosc Lett 1997; 230: 37-40.
12. Berthelot A, Luthringer C, Myers E, Exinger A. Disturbances of magnesium metabolism in the spontaneously hypertensive rat. J Am Coll Nutr 1997; 6: 329-332.
13. Laurant P, Dalle M, Berthelot A, Rayssiguier Y. Time course of the change in blood pressure level in magnesium-deficient Wistar rats. Br J Nutr 1999; 82: 243-251.
14. Luthringer C, Rayssiguier Y, Gueux E, Berthelot A. Effect of moderate magnesium deficiency on serum lipids, blood pressure and cardiovascular reactivity in normotensive rats. Br J Nutr 1988; 59: 243-250.
15. Turlapaty PDMV, Altura BM. Magnesium deficiency produces spasms of coronary arteries: relationship to etiology of sudden death ischemic heart disease. Science 1980; 208: 198-200.
16. Yang ZW, Wang J, Zheng T, Altura BT, Altura BM. Low extracellular magnesium contraction of arterial muscle: role of protein kinase C and protein tyrosine phosphorylation. Eur J Pharmacol 1999; 378: 273-281.
17. Zhang A, Cheng TPO, Altura BM. Magnesium regulates intracellular free ionized calcium concentration and cell geometry in vascular smooth muscle cells. Biochim Biophys Acta 1992; 1134: 25-29.
18. Altura BM, Altura BT. Magnesium and cardiovascular biology: an important link between cardiovascular risk factors and atherogenesis. Cell Mol Biol Res 1995; 41: 347-359.
19. Altura BM, Altura BT, Gebrewold A, Gunther T, Ising H. Noise-induced hypertension and magnesium: Relationship to microcirculation and magnesium. J Appl Physiol 1992; 72: 194-202.
20. Wu F, Altura BT, Gao J, Barbour RL, Altura BM. Ferrylmyoglobin formation induced by acute magnesium deficiency in perfused rat heart causes cardiac failure. Biochim Biophys Acta 1994; 1225: 158-164.
21. Chipperfield B, Chipperfield JR. Relation of myocardial metal concentrations to water hardness and death from ischemic heart disease. Lancet 1979; 2: 709-712.
22. Leary WP. Content of magnesium in drinking water and deaths from ischemic heart disease in White South Africans. Magnesium 1986; 5: 150-153.
23. Rayssiguier Y, Gueux E, Bussiere I, Durlach J, Mazur A. Dietary Magnesium affects susceptibility of lipoproteins and tissues to peroxidation in rats. J Am Coll Nutr 1993; 12: 133-137.
24. Saris NE, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A. Magnesium. An update on physiological, clinical and analytical aspects. Chim Acta 2000; 294: 1-26.
25. Altura BT, Brust M, Barbour RL, Stempak J, Bloom S, Altura BM. Magnesium dietary intake modulates blood lipid levels and atherogenesis. Proc Natl Acad Sci U S A 1990; 87: 1840-1844.
26. Joffres MR, Reed DM, Yano K. Relationship of magnesium intake and other dietary factors to blood pressure: the Honolulu heart study. Am J Clin Nutr 1987; 45: 469-475.
27. Seelig MS, Rosanoff A. The Magnesium Factor. New York: Penguin Group; 2003.
28. Altura BT, Altura BM. Measurement of ionized magnesium in whole blood, plasma and serum with a new ion-selective electrode in healthy and diseased human subjects. Magnes Trace Elem 1991; 10: 90-98.
29. Handwerker S, Altura BT, Royo B, Altura BM. Ionized magnesium and calcium levels in umbilical cord serum of pregnant women with transient hypertension during labor. Am J Hypertens 1993; 6: 542-545.
30. Christova T, Duridanova D, Setchenska M. Protein kinase C and smooth muscle contraction. Biomed Rev 1997; 8: 87-100.
31. Yang ZW, Wang J, Zheng T, Altura BT, Altura BM. Low extracellular Mg induces contraction and Ca2+ rises in cerebral arteries: roles of Ca2+, PKC and P-I-3 kinases. Am J Physiol Heart Circ 2000; 272: H2898-H2907.
32. Morrill GA, Gupta RK, Kostellow AB, Ma GY, Zhang A, Altura BT, Altura BM. Mg2+ modulates membrane lipids in vascular smooth muscle: a link to atherogenesis. FEBS Lett 1997; 408: 191-197.
33. Morrill GA, Gupta RK, Kostellow AB, Ma GY, Zhang A, Altura BT, Altura BM. Mg2+ modulates membrane sphingolipids and lipid second messengers in vascular smooth muscle cells. FEBS Lett 1998; 440: 167-171.
34. Altura BM, Gebrewold A, Zheng T, Altura BT. Sphingomyelinase and ceramide analogs induce vasoconstriction and leukocyte-endothelial interactions in cerebral venules in the intact brain: insight into mechanisms and possible relation to brain injury and stroke. Brain Res Bull 2002; 58: 271-278.
35. Auge N, Andrieu N, Negre-Salvayre R, Thiers JC, Levade T, Salvayre R. Sphingomyelin metabolites in vascular signaling and atherogenesis. Progr Lipid Res 2002; 39: 207-239.
36. Bischoff A, Czyborra P, Fetscher C, Meyer Zu Heringdorf D, Jacobs KH, Michel MC. Sphingosine-1-phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitro. Br J Pharmacol 2000; 130: 1871-1877.
37. Choi SK, Ahn DS, Lee YH. Comparison of contractile mechanisms of sphingosylphosphorylcholine and sphingosine-1-phosphate in rabbit coronary artery. Cardiovasc Res 2002; 82: 324-332.
38. Houck KL. Sphingolipid and phospholipid metabolites regulate the phenotype of vascular smooth muscle cells. PhD Thesis, Penn State Univ, 2008.
39. Michel MC, Mulders ACM, Jonsma M, Alewijinse AE, Peters SLM. Vascular effects of sphingolipids. Acta Paediatr 2007; 96: 44-48.
40. Zheng T, Li W, Wang J, Altura BT, Altura BM. Sphingomyelinase and ceramide analogs induce contraction and rises in [Ca2+] in canine cerebral vascular muscle. Am J Physiol Heart Circ Physiol 2000; 278: H1421-H1428.
41. Altura BM, Shah NC, Jiang XC, Li Z, Perez-Albela JL, Altura BT. Short-term magnesium deficiency results in decreased levels of serum sphingomyelin, lipid peroxidation, and apoptosis in cardiovascular tissues. Am J Physiol Heart Circ Physiol 2009; 297: H86-H92.
42. Altura BM, Shah NC, Li Z, Jiang XC, Perez-Albela JL, Altura BT. Magnesium deficiency upregulates serine palmitoyltransferase (SPT 1 and SPT 2) in cardiovascular tissues: relationship to serum ionized Mg and cytochrome C. Am J Physiol Heart Circ Physiol 2010; 299: H932-H938.
43. Altura BM, Shah NC, Li Z, Jiang XC, Zhang A, Li W, Zheng T, Perez-Albela JL, Altura BT. Short-term magnesium deficiency upregulates sphingomyelin synthase and p53 in cardiovascular tissues and cells: relevance to the de novo synthesis of ceramide. Am J Physiol Heart Circ Physiol 2010; 299: H2046-2055.
44. Altura BM, Shah NC, Shah G, Zhang A, Li W, Zheng T, Perez-Albela JL, Altura BT. Short-term magnesium deficiency upregulates ceramide synthase in cardiovascular tissues and cells: cross-talk among cytokines, Mg2+, NFkB and de novo ceramide. Am J Physiol Heart Circ Physiol 2012; 302: H319-H332.
45. Shah NC, Liu JP, Iqbal J, Hussain M, Jiang XC, Li Z, LiY, Zheng T, Li W, Sica AC, Perez-Albela JL, Altura BT, Altura BM. Mg deficiency results in modulation of serum lipids, glutathione, and NO synthase isozyme activation in cardiovascular tissues: relevance to de novo synthesis of ceramide, serum Mg and atherogenesis. Int J Clin Exp Med 2011; 4: 103-118.
46. Andrather J, Csizmadia V, Soares MP, Winkler H. Regulation of NF-kB RelA phosphorylation and transcription activity by p21 and protein kinase C zeta in primary endothelial cells. J Biol Chem 1999; 274: 13594-13603.
47. Becker KP, Kitakani K, Idkowiak-Baldys J, Bielawaski J, Hannun YA. Selective inhibition of juxtanuclear translocation of protein kinase C BIII by a negative feedback mechanism involving ceramide formed from the salvage pathway. J Biol Chem 2005; 280: 2606-2612.
48. Bourbon NA, Yun J, Kester M. Ceramide directly activates protein kinase C zeta to regulate a stress-activated protein kinase signaling pathway. J Biol Chem 2000; 275: 35617-35623.
49. Carlin S, Yang KXF, Donnelly R, Black JL. Protein kinase C isoforms in human airway smooth muscle cells: activation of PKC-zeta during proliferation. Am J Physiol Lung Cell Mol Physiol 1999; 20: L506-L512.
50. Hirai T, Chida K. Protein kinase C zeta (PKCzeta): activation mechanisms and cellular functions. J Biochem 2003; 133: 1-7.
51. Lallena MJ, Diaz-Meco MT, Bren G, Paya CV, Moscat J. Activation of IkB kinase beta by protein kinase C isoforms. Mol Cell Biol 1999; 19: 2180-2188.
52. Lozano J, Berra E, Munico MM, Diaz-Meco MT, Dominguez I, Sanz L, Moscat J. Protein kinase C zeta isoform is critical for kB-dependent promoter activation by sphingomyelinase. J Biol Chem 1994; 269: 19200-19202.
53. Mochly-Rosen D, Das K, Grimes KV. Protein kinase C, an elusive therapeutic target? Nat Rev Drug Disc 2012; 11: 937-957.
54. Muller G, Ayoouh M, Storz P, Rennecke J, Fabbro D, Pfizenmaier K. PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid. EMBO J 1995; 14: 1961-1969.
55. Wang G, Silva J, Krishnamurthy K, Tran E, Condie BG, Bieberich E. Direct binding to ceramide activates protin kinase C zeta before the formation of a pro-apoptotic complex with PAR-4 differentiating stem cells. J Biol Chem 2005; 280: 26415-26424.
56. Churchill E, Budas G, Vallentin A, Koyanagi T, Mochly-Rosen D. PKC isozymes in chronic disease: possible therapeutic targets. Annu Rev Pharmacol Toxicol 2008; 48: 569-599.
57. Diaz-Meco MT, Moscat J. The atypical PKCs in inflammation: NF-kB and beyond. Immunol Rev 2012; 246: 154-167.
58. Kitatani K, Idkowiak-Baldys J, Hannun YA. The sphingolipid salvage pathway in ceramide metabolism and signaling. Cell Signal 2008; 20: 469-475.
59. Kumar V, Abbas AK, Fausto N, Aster JC, Eds. Robbins and Cotran Pathologic Basis of Disease. Eighth Ed. Philadelphia: Saunders; 2010. pp: 487-506.
60. Steinberg SF. Cardiac actions of protein kinase C isoforms. Physiol 2012; 27: 130-139.
61. Altura BM, Gebrewold A, Zhang A, Altura BT. Low extracellular magnesium ions induces lipid peroxidation and activation of nuclear factor kappa B in canine cerebral vascular smooth muscle: possible relation to traumatic brain injury and strokes. Neurosci Lett 2003; 341: 189-192.
62. Altura BM, Kostellow AB, Zhang A, Li W, Morrill GA, Gupta RK, Altura BT. Expression of the nuclear factor-kappa B and proto-oncogenes c-fos and c-jun are induced by low extracellular Mg2+ in aortic and cerebral vascular smooth muscle cells: possible links to hypertension, atherogenesis and stroke. Am J Hypertens 2003; 16: 701-707.
63. Zheng T, Li W, Wang J, Altura BT, Altura BT. Effects of neutral sphingomyelinase on phenylephrine-induced vasoconstriction and Ca2+ mobilization in rat aortic smooth muscle. Eur J Pharmacol 1999; 191: 127-135.
64. Merrill AH Jr, Sullards MC, Allegood JC, Kelly S, Wang E. Sphingolipidomics: High-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrophotometry. Methods 2005; 36: 207-224.
65. He Q, Riley RT, Sharma RP. Fumonisin-induced tumor necrosis factor-alpha expression in a porcine kidney cell line is independent of sphingold base accumulation induced by ceramide synthase inhibition. Toxicol Appl Pharmacol 2001; 174: 69-77.
66. Yoo HS, Norred WP, Showker J, Riley RT. Elevated sphingoid bases and complex sphingolipid depletion as contributing factors in fumonisin-induced cytotoxicity. Toxicol Appl Pharmacol 2001; 138: 211-218.
67. Hannun YA, Obeid LM. The ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. J Biol Chem 2002; 277: 25847-25850.
68. Kolesnick R. Signal transduction through the sphingomyelin pathway. Mol Chem Neuropathol 1994; 21: 287-297.
69. Villani M, Subathra M, Im YB, Choi Y, Signorelli P, Del Poeta M, Luberto C. Sphingomyelin synthases regulate production of diacylglycerol at the Golgi. Biochem J 2008; 414: 31-41.
70. Jaffrezou JP, Maestre N, de Mas-Mansat V, Bezombes C, Levade T, Laurent G. Positive feedback control of sphingomyelinase activity by ceramide. FASEB J 1998; 12: 999-1006.
71. Luberto C, Hannun YA. Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. J Biol Chem 1998; 273: 14550-9.
72. Pandey S, Murphy RF, Agarawal DK. Recent advances in the immunobiology of ceramide. Exp Mol Pathol 2007; 82: 298-309.
73. Perry DK, Carton J, Shah AK, Meredith F, Uhlingeri DJ, Hannun YA. Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis. J Biol Chem 2000; 275: 9078-9084.
74. Vandrager AB, Houweling M. Effect of ceramides on phospholipid biosynthesis and its implications for apoptosis. In: Quinn PJ, Kagan PJ, eds. Phospholipid Metabolism in Apoptosis. New York: Kluwer Academic; 2002. pp: 207-227.
75. Andrieu-Abadie N, Gouaze V, Salvayre R, Levade T. Ceramide in apoptosis signaling: relationship with oxidative stress. Free Rad Biol Med 2001; 31: 717-728.
76. Birbes H, Bawab SE, Hannun YA, Obeid LM. Selective hydrolysis of a mitochondrial pool of sphingomyelin induces apoptosis. FASEB J 2001; 14: 2669-2679.
77. Haimovitz-Friedman A, Kolesnick RN, Fuks Z. Ceramide signaling in apoptosis. Br Med Bull 1997; 53: 539-553.
78. Meng A, Luberto C, Meier P, Bai A, Yang X, Hannun YA, Zhou D. Sphingomyelin synthase as a potential target for D609-induced apoptosis in U937 humanmonocytic leukemia cells. Exp Cell Res 2004; 292: 385-392.
79. Ohta H, Sweeney EA, Masamune A, Yatomi Y, Hakomori SI, Igarashi Y. Induction of apoptosis by sphingosine in human leukemic HL-60 cells: A possible endogenous modulator of apoptotic DNA fragmentation occurring during phorbol ester-induced differentiation. Anal Biochem 1994; 222: 489-494.
80. Panjarian S, Kozhaya L, Arayssi S, Bielawski YM, Usta J, Hannun YA, Obeid LM, Dbalbo GS. De novo N-palmitoylsphingosine synthesis is the major biochemical mechanism of ceramide accumulation following p53 up-regulation. Prost Other Lipid Med 2008; 86: 41-48.
81. Voelker DR, Kennedy EP. Cellular and enzymatic synthesis of sphingomyelin. Biochem 1992; 21: 2753-2759.
82. Krishnamurthy K, Wang G, Siva J, Condie G, Bieberich E. Ceramide regulates atypical PKCzeta-mediated cell polarity in primitive ectoderm cells. J Biol Chem 2007; 282: 3379-3390.
83. Parmentier JH, Smelcer P, Pavicevic Z, Basic E, Idrizvic A, Estes A. PKC-zeta mediates norepinephrine-induced phospholipase D activation and cell proliferation in VSMC. Hypertens 2003; 41: 794-800.
84. Phillipson A, Petermann EE, Taormina P, Harvey M, Brue RJ, Atkinson N, Omiyi D, Chukwu C, Young LH. Protein kinase C-zeta inhibition exerts cardioprotective effects in ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2005; 289: H898-H907.
85. Shin HG, Barnett JV, Chang P, Reddy S, Drinkwater DC, Pierson RN, Wiley RG, Murray KT. Molecular heterogeneity of protein kinase C expression in human ventricle. Cardiovasc Res 2000; 48: 285-299.
86. Yang ZW, Gebrewold A, Nowakowski M, Altura BT, Altura BM. Mg2+ induced endothelial-dependent relaxation of blood vessels and blood pressure lowering: role of NO. Am J Physiol Regul Integr Comp Physiol Physiol 2000; 278: R628-R639.
87. Li JF, Li W, Altura BT, Altura BM. Peroxynitrite induces apoptosis and decline of intracellular free Mg2+ with concomitant elevation in [Ca2+] in rat aortic smooth muscle cells: possible roles of extracellular and intracellular magnesium ions in peroxynitrite-induced cell death. Drug Metab Lett 2007; 1: 85-89.
88. Tejero-taldo ML, Chmelinska JJ, Weglicki WB. Chronic dietary Mg2+ deficiency induces cardiac apoptosis in the rat heart. Magnes Res 2007; 20: 208-212.
89. Campbell JH, Campbell GR. Smooth muscle phenotype modulation-A personal experience. Arterioscl Thromb Vasc Biol 2012; 32: 1784-1789.
90. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertens 2001; 38: 581-587.
91. Mulvany MJ. Small artery remodeling and significance in the development of hypertension. News Physiol Sci 2002; 17: 105-109.
92. Andreassi M. Coronary atherosclerosis and somatic mutations: an overview of the contributive factors for oxidative DNA damage. Mutat Res 2003; 543: 67-86.
93. Mercer J, Mahmoudi M, Bennett M. DNA damage, p53, apoptosis and vascular disease. Mutat Res 2007; 621: 75-86.
94. Rosannoff A. Magnesium supplements may enhance the effect of antihypertensive medications in stage 1 hypertensive subjects. Magnes Res 2010; 23: 27-40.
95. Kobayashi J. On geographical relationship between the chemical nature of river water and death from apoplexy. Berichte des Ohara Inst fur Landwirtsch Biol 1957; 11: 12-21.